President and CEO Alison Moore outlined the company’s strategic focus on RNA medicines manufacturing at TD Cowen’s 46th ...

Astronomers have found that both the core of our Milky Way and the earliest proto-galaxies in the universe share a surprising ...

A team from University of Toronto Engineering is the first to synthesize long noncoding RNA (lncRNA) outside the cell—a new approach to drug discovery that has already yielded some promising ...

Rotator cuff tears often heal with stiff, dysfunctional scar tissue, limiting recovery. A new study reveals why tendon ...

A new study led by Pierre Close's team (GIGA, Laboratory of Cancer Signaling, and WELRI Investigator) reveals how subtly ...

A recent study published in Engineering has shed light on a novel therapeutic target for improving anti-angiogenic treatment in colorectal cancer (CRC). The research, conducted by an international ...

Codexis inks agreement with an innovator pharma company to manufacture 50 grams siRNA using its ECO Synthesis platform: Redwood City, California Friday, March 6, 2026, 11:00 Hrs [ ...

A remarkably small bacterium containing fewer than 500 genes serves as the basis for one of the most detailed digital life ...

A new study led by Pierre Close's team (GIGA, Laboratory of Cancer Signaling, and WELRI Investigator) reveals how subtly disrupting the way tumors produce their proteins can trigger a potent antitumor ...

A recent study published in Engineering has shed light on a novel therapeutic target for improving anti-angiogenic treatment in colorectal cancer (CRC).

The mechanism of action of mRNA vaccines goes far beyond harnessing host cellular machinery to produce antigenic proteins to spur immunity, write Nicolas Hulscher, M.P.H., Peter A. McCullough, M.D., M ...